IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Effector Therapeutics Inc

Q3 2023 vs Q4 2023

Comparing institutional holders between quarters

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Sabby Management, LLC
NEW
Shares100,000
Change+100,000
Value$46.7K
Filed 2024-02-14
Status
Sabby Management, LLC
NEW100,000—+100,000——$46.7K—2024-02-14
Showing 1 of 1 institutions